Aliases & Classifications for Blepharitis

Summaries for Blepharitis

Disease Ontology : 12 An eyelid disease that is characterized by often chronic inflammation of the eyelid, generally the part where eyelashes grow.

MalaCards based summary : Blepharitis is related to ectropion and ulcerative blepharitis. An important gene associated with Blepharitis is SAT1 (Spermidine/Spermine N1-Acetyltransferase 1), and among its related pathways/superpathways are IL-17 Family Signaling Pathways and Protein processing in endoplasmic reticulum. The drugs Azithromycin and Doxycycline have been mentioned in the context of this disorder. Affiliated tissues include eye, skin and testes.

Wikipedia : 72 Blepharitis (/blɛfəˈraɪtɪs/ BLEF-ər-EYE-tis) is a common eye condition characterized by inflammation of... more...

Related Diseases for Blepharitis

Diseases related to Blepharitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 83)
id Related Disease Score Top Affiliating Genes
1 ectropion 30.0 IL4 MMP9
2 ulcerative blepharitis 12.0
3 squamous blepharitis 11.9
4 blepharoconjunctivitis 11.2
5 keratosis follicularis spinulosa decalvans, x-linked 10.9
6 ichthyosis, congenital, autosomal recessive 11 10.8
7 hordeolum externum 10.8
8 eyelid disease 10.8
9 meibomian cyst 10.8
10 autism x-linked 4 10.7 MBTPS2 SAT1
11 kidney cancer, childhood 10.7 MBTPS2 SAT1
12 dysentery 10.7 MBTPS2 SAT1
13 communicating hydrocephalus 10.6 MBTPS2 SAT1
14 solitary cyst of breast 10.5 CCL11 MMP9
15 influenza 10.5 CCL11 MMP9
16 otosclerosis 4 10.4 MBTPS2 SAT1
17 urethral intrinsic sphincter deficiency 10.4 IL4 MMP9
18 cholesteatoma of middle ear 10.4 CCL11 SHE
19 congenital structural myopathy 10.3 MBTPS2 SAT1
20 psychotic disorder 10.3 CCL11 IL4
21 retinal vascular disease 10.3 CCL11 IL4
22 apple allergy 10.3 CCL11 IL4
23 fungal gastritis 10.3 CCL11 IL4
24 trachea leiomyoma 10.3 CCL11 IL4
25 female urethral cancer 10.3 CCL11 IL4
26 fibrous histiocytoma 10.3 CCL11 IL4
27 angiomyoma 10.2 CCL11 IL4
28 progressive relapsing multiple sclerosis 10.2 IL4 MMP9
29 leukocyte disease 10.2 CCL11 IL4
30 inflamed seborrheic keratosis 10.2 CCL11 IL4
31 eyelid neoplasm 10.2 CCL11 IL4
32 acute contagious conjunctivitis 10.2 CCL11 IL4
33 conjunctivitis 10.2
34 subcorneal pustular dermatosis 10.2 CCL11 IL4
35 dehydration polycythemia 10.2 CCL11 IL4
36 pelvic varices 10.1 CCL11 IL4
37 dentin caries 10.1 CCL11 IL4
38 benign mammary dysplasia 10.0 CCL11 IL4
39 dioctophymiasis 10.0 CCL11 IL4 MMP9
40 epididymis adenocarcinoma 10.0 CCL11 IL4 MMP9
41 viljoen kallis voges syndrome 10.0 CCL11 IL4 MMP9
42 acute chest syndrome 10.0 CCL11 IL4 MMP9
43 germ cell and embryonal cancer 10.0 IL4 MMP9
44 herpes simplex 10.0
45 lupus erythematosus 10.0
46 rosacea 9.9
47 discoid lupus erythematosus 9.9
48 corneal intraepithelial neoplasm 9.9 CCL11 IL4
49 anterior dislocation of lens 9.9 CCL11 IL4 SHE
50 histiocytic and dendritic cell cancer 9.9 CCL11 IL4 LACRT

Comorbidity relations with Blepharitis via Phenotypic Disease Network (PDN):


Acute Cystitis Conjunctivitis
Deficiency Anemia Familial Atrial Fibrillation
Heart Disease Hypertension, Essential
Parkinson Disease, Late-Onset Schizophreniform Disorder

Graphical network of the top 20 diseases related to Blepharitis:



Diseases related to Blepharitis

Symptoms & Phenotypes for Blepharitis

Drugs & Therapeutics for Blepharitis

Drugs for Blepharitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 106)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Azithromycin Approved Phase 4,Phase 3,Phase 2 83905-01-5 55185 53477736 447043
2
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2 564-25-0 54671203
3
Minocycline Approved, Investigational Phase 4 10118-90-8 5281021
4
Acitretin Approved Phase 4 55079-83-9 6437841 5284513
5
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741 24759
6
Ephedrine Approved Phase 4,Phase 3,Phase 1,Phase 2 299-42-3 9294
7
Pseudoephedrine Approved Phase 4,Phase 3,Phase 1,Phase 2 90-82-4 7028
8
Erythromycin Approved, Vet_approved Phase 4 114-07-8 12560
9
Loteprednol Approved Phase 4,Phase 3,Phase 2 82034-46-6, 129260-79-3 444025 9865442
10
Tobramycin Approved, Investigational Phase 4,Phase 3 32986-56-4 5496 36294
11
Glycerol Approved, Investigational Phase 4 56-81-5 753
12
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-02-2 5743
13
Dipivefrin Approved Phase 4,Phase 3 52365-63-6 3105
14
Chloramphenicol Approved, Vet_approved Phase 4 56-75-7 298 5959
15
Formaldehyde Approved, Vet_approved Phase 4 50-00-0 712
16
Fusidic Acid Approved Phase 4 6990-06-3 3000226
17
Permethrin Approved, Investigational Phase 4 52645-53-1 40326
18
Chloramphenicol succinate Experimental Phase 4 3544-94-3
19 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
20 Anti-Infective Agents Phase 4,Phase 3,Phase 2
21 Antimalarials Phase 4,Phase 2
22 Antiparasitic Agents Phase 4,Phase 3,Phase 2
23 Antiprotozoal Agents Phase 4,Phase 3,Phase 2
24 Dermatologic Agents Phase 4
25 Keratolytic Agents Phase 4
26 Ophthalmic Solutions Phase 4,Phase 3,Phase 1,Phase 2
27 Pharmaceutical Solutions Phase 4,Phase 3,Phase 1,Phase 2
28 Tetrahydrozoline Phase 4,Phase 3,Phase 1,Phase 2
29 Adjuvants, Immunologic Phase 4
30 Protective Agents Phase 4
31 Viscosupplements Phase 4
32 Autonomic Agents Phase 4,Phase 3,Phase 1,Phase 2
33 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1,Phase 2
34 Nasal Decongestants Phase 4,Phase 3,Phase 1,Phase 2
35 Respiratory System Agents Phase 4,Phase 3,Phase 1,Phase 2
36 Vasoconstrictor Agents Phase 4,Phase 3,Phase 1,Phase 2
37 Erythromycin Estolate Phase 4
38 Erythromycin Ethylsuccinate Phase 4
39 Erythromycin stearate Phase 4
40 Gastrointestinal Agents Phase 4,Phase 3,Phase 2
41 Anti-Allergic Agents Phase 4,Phase 3,Phase 2
42 Antibiotics, Antitubercular Phase 4,Phase 3
43 Lubricant Eye Drops Phase 4,Phase 1,Phase 2
44 Carboxymethylcellulose Sodium Phase 4,Phase 3
45 Cathartics Phase 4,Phase 3
46 Laxatives Phase 4,Phase 3
47 Antiemetics Phase 4,Phase 3,Phase 2
48 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2
49 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2
50 BB 1101 Phase 4,Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 54)

id Name Status NCT ID Phase Drugs
1 Lipids of the Human Tear Film and Their Effect on Tear Stability Unknown status NCT00803452 Phase 4 doxycycline;essential fatty acid;azithromycin
2 A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome Unknown status NCT00344721 Phase 4 Essential fatty acid supplement
3 Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects? Unknown status NCT01228409 Phase 4 Acitretin 17.5 mg/day
4 Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis Completed NCT01478256 Phase 4 Erythromycin;Besifloxocin
5 Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis Completed NCT01357538 Phase 4 Posiformin 2 %, bibrocathol;Placebo Comparator
6 Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis Completed NCT00629941 Phase 4 AzaSite®
7 Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis Completed NCT00629980 Phase 4 AzaSite®
8 Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis Completed NCT00629590 Phase 4 AzaSite®
9 Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis Completed NCT00656539 Phase 4 AzaSite®
10 Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis Completed NCT01456780 Phase 4 Loteprednol/tobramycin;Loteprednol;B+L Advanced Eye Relief Lubricant Drop
11 Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye Completed NCT00987727 Phase 4 carboxymethylcellulose 0.5% , glycerin 0.9% (OPTIVE® MD);sodium hyaluronate 0.18% (VISMED® Multi)
12 Zylet vs TobraDex in Blepharokeratoconjunctivitis Completed NCT00447577 Phase 4 Loteprednol etabonate and tobramycin ophthalmic suspension;Tobramycin and dexamethasone ophthalmic suspension
13 The Efficacy of Permethrin 5% Treatment for Demodex - Blepharitis in Comparison to Fucithalmic (Fusidic Acid 1%) and Synthomycine 5% Enrolling by invitation NCT03105505 Phase 4 Permethrin 5%;Synthomycine 5%;Fusidic Acid 1% M/R Eye Drops
14 A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis Completed NCT01102244 Phase 3 Tobradex ST;Azasite
15 Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis Completed NCT01408082 Phase 3 ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined);Azasite;Dexamethasone
16 Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% Completed NCT02236403 Phase 3 Ivermectin 0.1% Metronidazole 1%
17 Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis Completed NCT00732446 Phase 3 Moxifloxacin and Dexamethasone combined;Moxifloxacin;Dexamethasone
18 Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes Completed NCT00796926 Phase 3 Systane Ultra eyedrops;Refresh eye drops
19 Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis Completed NCT01028027 Phase 3 Loteprednol and tobramycin;Tobramycin and dexamethasone
20 Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects Not yet recruiting NCT01543490 Phase 3 ISV-305
21 Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection Withdrawn NCT01721694 Phase 3 azithromycin 1.5%/Loteprednol 0,5% + placebo;azithromycin 1.5% + Loteprednol 0,5% (separately)
22 Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion. Unknown status NCT02300818 Phase 1, Phase 2 Seawater eyedrops
23 Oral Azithromycin Versus Doxycycline in Posterior Blepharitis Completed NCT01783860 Phase 2 Azithromycin;Doxycycline
24 Tea Tree Oil in the Treatment of Chronic Blepharitis Completed NCT01073150 Phase 2 Tea Tree Oil
25 Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis Completed NCT01089608 Phase 2 Azithromycin;Povidone
26 Topical IL-1-Ra for Treatment of Posterior Blepharitis Completed NCT00681109 Phase 1, Phase 2 2.5% IL-1Ra;Placebo;5% IL-1Ra
27 Treatment of Patients With Blepharitis and Facial Rosacea Completed NCT00560703 Phase 2 COL-101 (doxycycline, USP) capsules;placebo
28 The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period Completed NCT00892970 Phase 2 Azithromycin ophthalmic solution, 1%;Placebo
29 The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638) Completed NCT00894530 Phase 2 Azithromycin ophthalmic solution, 1%;Placebo
30 Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease Completed NCT02218489 Phase 2 KPI-121;Vehicle
31 Evaluation and Treatment of Eye Complications of Vaccinia Vaccination Completed NCT00081835 Phase 2 NP-016 Vaccine Immune Globulin (IV-VIG)
32 A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636) Terminated NCT01269658 Phase 2 Azithromycin ophthalmic solution, 1%;Vehicle
33 A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641) Terminated NCT01220258 Phase 2 Azithromycin ophthalmic solution, 1%
34 A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates Terminated NCT00579020 Phase 2 Moxifloxacin/dexamethasone phosphate ophthalmic solution;Moxifloxacin ophthalmic solution 0.5%;Dexamethasone phosphate solution, 0.1%
35 Demodex Blepharitis Treatment Study Completed NCT01647217 Phase 1 Terpinen-4-ol
36 Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora Unknown status NCT02455895
37 Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma Unknown status NCT01284439 hydroxypropylmethylcellulose;sodium hyaluronate
38 Blephacura Versus Baby Shampoo to Treat Blepharitis Completed NCT01115192
39 Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery Completed NCT01808560
40 Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points Completed NCT00345241 Systane Ocular Drops (OTC);Placebo - Saline Drops
41 Investigation of Chronic Inflammatory Processes in Male Individuals With Hypohidrotic Ectodermal Dysplasia Completed NCT01308333
42 Evaluation and Treatment of Patients With Corneal and External Diseases Completed NCT00008541
43 Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate Completed NCT01692652 topical loteprednol etabonate (lotemax 0.5%) with warm compress & ocular massage
44 Effects of Minocycline on Cytokine Levels in Severe Meibomian Gland Dysfunction Completed NCT01600625 oral minocycline hydrochloride treatment
45 To Compare Blephapad Combo vs Standard Treatment for Eyelid Cleansing in Bilateral Posterior Blepharitis Recruiting NCT03301844
46 Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis Recruiting NCT02952079
47 Ocular Comfort and Inflammation in Lid Hygiene Therapy Recruiting NCT02938078
48 Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa Recruiting NCT02386774
49 Effect of Meibomian Gland Probing on Ocular Surface in Ocular Rosacea Recruiting NCT02735681
50 mDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX) Recruiting NCT02397109

Search NIH Clinical Center for Blepharitis

Cochrane evidence based reviews: blepharitis

Genetic Tests for Blepharitis

Genetic tests related to Blepharitis:

id Genetic test Affiliating Genes
1 Blepharitis 29

Anatomical Context for Blepharitis

MalaCards organs/tissues related to Blepharitis:

39
Eye, Skin, Testes

Publications for Blepharitis

Articles related to Blepharitis:

(show top 50) (show all 257)
id Title Authors Year
1
Blepharitis With Facial Numbness and Ocular Pain. ( 28880989 )
2017
2
Unilateral Blepharitis With Fine Follicular Scaling. ( 28920471 )
2017
3
Demodex Blepharitis Treated with a Novel Dilute Povidone-Iodine and DMSO System: A Case Report. ( 28643231 )
2017
4
Meibography for eyes with posterior blepharitis. ( 28860908 )
2017
5
Tacrolimus Ointment for Refractory Posterior Blepharitis. ( 28922018 )
2017
6
Ten-year incidence and prevalence of clinically diagnosed blepharitis in South Korea: a nationwide population-based cohort study. ( 28183148 )
2017
7
Retraction of: Azithromycin 1.5% Ophthalmic Solution for Blepharitis Treatment: Comparison of 14- Versus 30-Day Treatment; DOI: 10.1089/jop.2015.0099. ( 28605219 )
2017
8
High prevalence of Demodex spp. infestation among patients with posterior blepharitis: correlation with age and cylindrical dandruff. ( 28552438 )
2017
9
Loteprednol Etabonate 0.5%/Tobramycin 0.3% Compared with Dexamethasone 0.1%/Tobramycin 0.3% for the Treatment of Blepharitis. ( 26788833 )
2016
10
The Effect of Demodex Infestation on Blepharitis and the Ocular Symptoms. ( 26783981 )
2016
11
Recurrent Fungal Keratitis and Blepharitis Caused by Aspergillus flavus. ( 27621301 )
2016
12
Demodex folliculorum: Following the trail to chronic blepharitis. ( 26775083 )
2016
13
Comparison of therapeutic effects of topical azithromycin solution and systemic doxycycline on posterior blepharitis. ( 27500111 )
2016
14
A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin-0.1% dexamethasone combination compared to 1% azithromycin alone, 0.1% dexamethasone alone, and vehicle in the treatment of subjects with blepharitis. ( 27570444 )
2016
15
DEBS - a unification theory for dry eye and blepharitis. ( 28003734 )
2016
16
Treatment With Doxycycline for Severe Bortezomib-Associated Blepharitis. ( 27349766 )
2016
17
Oral azithromycin and blepharitis: symptoms and signs improve, so where are the publications? ( 27356302 )
2016
18
Meibomian gland dysfunction: azithromycin and objective improvement in outcomes in posterior blepharitis. ( 27314917 )
2016
19
Efficacy and Safety of Topical Atorvastatin for the Treatment of Dry Eye Associated with Blepharitis: A Pilot Study. ( 26068735 )
2015
20
Blepharitis: remains a diagnostic enigma. A role for tea tree oil shampoo? ( 26293141 )
2015
21
Periodic acid-Schiff staining demonstrates fungi in chronic anterior blepharitis. ( 26293142 )
2015
22
Cheek and periorbital peculiar discoid lupus erythematosus: rare clinical presentation mimicking tinea faciei, cutaneous granulomatous disease or blepharitis. ( 25969679 )
2015
23
Acute blepharitis: an unusual complication of zoledronic acid. ( 26412501 )
2015
24
WITHDRAWN: Azithromycin 1.5% Ophthalmic Solution for Blepharitis Treatment: Comparison of 14- Versus 30-Day Treatment. ( 26717146 )
2015
25
Common Blepharitis Related to Phthiriasis Palpebrarum: Argon Laser Phototherapy. ( 26470938 )
2015
26
Medical management of blepharitis. ( 26058027 )
2015
27
Treatment Options for Demodex Blepharitis: Patient Choice and Efficacy. ( 25902082 )
2015
28
Comparative study of the efficacy of different treatment options in patients with chronic blepharitis. ( 25542616 )
2015
29
Utilisation of a Novel Test to Measure Severity and Treatment Efficacy of Posterior Blepharitis. ( 26347811 )
2015
30
STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitis. ( 24845637 )
2014
31
Malassezia spp on the periocular skin of dogs and their association with blepharitis, ocular discharge, and the application of ophthalmic medications. ( 24846431 )
2014
32
Staphylococcus aureus Blepharitis Associated with Multiple Corneal Stromal Microabscess, Stromal Edema, and Uveitis. ( 24410378 )
2014
33
Herpes simplex virus blepharitis in a patient with Crohn's colitis. ( 24613714 )
2014
34
Treatment of blepharitis: recent clinical trials. ( 25284773 )
2014
35
Intraductal meibomian gland probing for the treatment of blepharitis. ( 25001110 )
2014
36
Blepharitis: always remember demodex. ( 25371637 )
2014
37
Ocular rosacea: an underdiagnosed cause of relapsing conjunctivitis-blepharitis in the elderly. ( 25239991 )
2014
38
Two cases of tinea ciliaris with blepharitis due to Microsporum audouinii and Trichophyton verrucosum and review of the literature. ( 24724801 )
2014
39
A novel gammaherpesvirus in a large flying fox (Pteropus vampyrus) with blepharitis. ( 23628640 )
2013
40
Patients with blepharitis are at elevated risk of anxiety and depression. ( 24386181 )
2013
41
More than scratching the surface: a shift of focus in blepharitis management. ( 23902351 )
2013
42
Assessment of the tolerability profile of an ophthalmic solution of 5% glycyrrhizin and copolymer PEG/PPG on healthy volunteers and evaluation of its efficacy in the treatment of moderate to severe blepharitis. ( 23874081 )
2013
43
Demodex blepharitis mimicking eyelid sebaceous gland carcinoma. ( 23565576 )
2013
44
Fas deficiency in mice with the Balb/c background induces blepharitis with allergic inflammation and hyper-IgE production in conjunction with severe autoimmune disease. ( 23220580 )
2013
45
Assessment of signs of anterior blepharitis using standardized color photographs. ( 24055901 )
2013
46
Ethyl ether: an old ally against oral ivermectin resistant demodex blepharitis. ( 24269425 )
2013
47
Chronic blepharitis. ( 23799315 )
2013
48
Severe chronic blepharitis and scarring ectropion associated with discoid lupus erythematosus. ( 22845188 )
2013
49
Interventions for chronic blepharitis. ( 22592706 )
2012
50
Eyelid margin modification associated with eyelid hygiene in anterior blepharitis and meibomian gland dysfunction. ( 22890229 )
2012

Variations for Blepharitis

Expression for Blepharitis

Search GEO for disease gene expression data for Blepharitis.

Pathways for Blepharitis

GO Terms for Blepharitis

Biological processes related to Blepharitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 negative regulation of apoptotic process GO:0043066 9.46 CRYAA IL4 LACRT MMP9
2 positive regulation of release of cytochrome c from mitochondria GO:0090200 9.26 MMP9 PLA2G6
3 positive regulation of protein phosphorylation GO:0001934 9.13 IL4 MMP9 PLA2G6
4 chemotaxis GO:0006935 8.8 CCL11 IL4 PLA2G6

Sources for Blepharitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....